Article
NIS2 makes resilience in the pharmaceutical industry a strategic leadership priority, requiring an integrated operating model that harmonizes compliance, cybersecurity, and business continuity.
msg advisors
AI in the regulated GxP environment: Dr Hans Klöcker explains how pharmaceutical companies validate AI solutions and ensure safe, compliant operation.
msg advisors
Transparency for your processes: Use process mining to identify inefficiencies and optimisation potential in order to reduce costs and accelerate workflows.
msg advisors
Security for critical infrastructures: Learn how KRITIS guidelines and business continuity management interact in the pharmaceutical industry.
Article
Many companies only use a fraction of XM's potential. What needs to be changed?
Article
Process mining helps identify efficiency gaps in existing business processes. This benefits companies in two ways.
Article
End users as a “critical factor” for successful rollouts: What companies should pay attention to.
Article
Pharmaceutical companies need particularly responsive and professional emergency and crisis management.